APA (7th ed.) Citation

Yunlin Jiang, Yunlin Jiang, Mingye Zhao, Jiayi Xi, Jiaqi Li, Wenxi Tang, & Xueping Zheng. (2023). Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: A United Kingdom health care perspective. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yunlin Jiang, Yunlin Jiang, Mingye Zhao, Jiayi Xi, Jiaqi Li, Wenxi Tang, and Xueping Zheng. Cost-effectiveness Analysis of Atezolizumab in Patients with Non-small-cell Lung Cancer Ineligible for Treatment with a Platinum-containing Regimen: A United Kingdom Health Care Perspective. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Yunlin Jiang, et al. Cost-effectiveness Analysis of Atezolizumab in Patients with Non-small-cell Lung Cancer Ineligible for Treatment with a Platinum-containing Regimen: A United Kingdom Health Care Perspective. Frontiers Media S.A., 2023.